Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M. C. Wani is active.

Publication


Featured researches published by M. C. Wani.


Cancer Research | 2004

Hydrophilic Camptothecin Analogs That Form Extremely Stable Cleavable Complexes with DNA and Topoisomerase I

Randy M. Wadkins; David J. Bearss; Govindarajan Manikumar; M. C. Wani; Monroe E. Wall; Daniel D. Von Hoff

Camptothecin (CPT) analogs that form more stable ternary complexes with DNA and topoisomerase I (termed cleavable complexes) show greater activity in their ability to inhibit tumor cell line growth in preclinical studies. Based on our earlier work, we hypothesized that analogs bearing hydrogen bonding moieties at the 7- through 10-position of CPT would result in more stable cleavable complexes. Consequently, we synthesized analogs with 7-mono-, 7-di-, and 7-trihydroxymethylaminomethyl groups. These analogs showed increasing cleavable complex stability as the number of hydroxyl groups was increased. The 7-trihydroxymethylaminomethyl analog of 10,11-methylenedioxycamptothecin (THMAM-MD) showed remarkable ternary complex stability with a half-life of 116 minutes. This is an order of magnitude more stable than any previously examined analog. Our in vitro analysis demonstrated that these analogs were all potent topoisomerase I poisons and could inhibit tumor cell growth in culture. We studied the effects of THMAM-MD in vivo in severe combined immunodeficient mice bearing HT-29 colon cancer and MiaPaCa-2 pancreatic cancer tumors. The THMAM-MD analog showed excellent, persisting activity in inhibiting tumor growth with both lines. Taken together, our results suggest that CPTs with hydrophilic, hydrogen-bonding groups at the 7-position hold the promise of excellent clinical activity.


Current Medicinal Chemistry - Anti-cancer Agents | 2004

Topoisomerase I-DNA complex stability induced by camptothecins and its role in drug activity.

Randy M. Wadkins; David J. Bearss; Govindarajan Manikumar; M. C. Wani; Monroe E. Wall; Daniel D. Von Hoff

The mechanism of cytotoxicity of the camptothecin family of antitumor drugs is thought to be the consequence of a collision between moving replication forks and camptothecin-stabilized cleavable DNA-topoisomerase I complexes. One property of camptothecin analogs relevant to their potent antitumor activity is the slow reversal of the cleavable complexes formed with these drugs. The persistence of cleavable complexes with time may be an essential property for increasing the likelihood of a collision between the replication fork and a cleavable complex, giving rise to lethal DNA lesions. In this paper, we examined a number of camptothecin analogs forming cleavable complexes with distinctly different stabilities. Absolute reaction rate analysis was carried out for each derivative. Our results indicate that the stability of the cleavable complex is dominated by the activation entropy (DeltaS++) of the reversal process. We measured the relative lipophilicity of the CPT analogs by reverse-phase HPLC, but the DeltaS++ of complex reversal is not directly related to the lipophilicity of the CPT analog being used. We suggest that solvent ordering around the 7- through 10-position of the CPT ring may be responsible for reversal rates dependence on DeltaS++. We demonstrate that the cleavable complex stability conferred by each camptothecin analog is directly correlated with the induction of apoptosis and cytotoxicity to tumor cells.


Journal of The Chemical Society D: Chemical Communications | 1970

Plant antitumour agents: alkaloids: synthesis of a pentacyclic camptothecin precursor

M. C. Wani; John A. Kepler; James B. Thompson; Monroe E. Wall; Samuel G. Levine

A pentacyclic product (VIII) suitable for conversion into camptothecin (I)2 has been synthesized.


Journal of the American Chemical Society | 1971

PLANT ANTITUMOR AGENTS. VI. THE ISOLATION AND STRUCTURE OF TAXOL, A NOVEL ANTILEUKEMIC AND ANTITUMOR AGENT FROM TAXUS BREVIFOLIA

M. C. Wani; Harold Taylor; Monroe E. Wall; Philip Coggon; Andrew T. McPhail


Journal of Organic Chemistry | 1969

Plant antitumor agents. II. Structure of two new alkaloids from Camptotheca acuminata

M. C. Wani; Monroe E. Wall


Molecular Pharmacology | 2000

7- and 10-substituted camptothecins: dependence of topoisomerase I-DNA cleavable complex formation and stability on the 7- and 10-substituents.

Bogdan Vladu; Jan M. Woynarowski; Govindarajan Manikumar; M. C. Wani; Monroe E. Wall; Daniel D. Von Hoff; Randy M. Wadkins


Journal of the American Chemical Society | 1972

Plant antitumor agents. IX. The total synthesis of dl-camptothecin.

M. C. Wani; H. F. Campbell; G. A. Brine; John A. Kepler; Monroe E. Wall; Samuel G. Levine


Journal of Organic Chemistry | 1969

Plant antitumor agents. IV. An approach toward the synthesis of camptothecin

John A. Kepler; M. C. Wani; J. N. McNaull; Monroe E. Wall; Samuel G. Levine


Journal of Natural Products | 1987

Plant Antitumor Agents, 24. Rapid 9-KB Assay

Monroe E. Wall; Harold Taylor; M. C. Wani


Bioorganic & Medicinal Chemistry Letters | 2004

Camptothecin analogs with bulky, hydrophobic substituents at the 7-position via a Grignard reaction.

Govindarajan Manikumar; Randy M. Wadkins; David J. Bearss; Daniel D. Von Hoff; M. C. Wani; Monroe E. Wall

Collaboration


Dive into the M. C. Wani's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daniel D. Von Hoff

Translational Genomics Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge